Canada added a single-dose COVID-19 vaccine to its pandemic-fighting arsenal on Friday, approving Johnson & Johnson's product a week after it was authorized in the United States.
A single dose of Pfizer-BioNTech's COVID-19 vaccine is barely enough to cover the average pinky nail but is made up of more than 280 components and requires at least three manufacturing plants to produce.
Canada is poised to receive a record number of COVID-19 vaccine doses this week thanks to scheduled deliveries from Pfizer-BioNTech and Moderna, as the country looks to speed up its vaccination efforts.
A month-long slowdown in Canada's COVID-19 vaccine deliveries should end next week, with the single biggest shipment of vaccines from Pfizer and BioNTech to date and almost two million doses expected in the next month.
In the end, what most Canadians want isn’t an election over the COVID vaccination program but an effective and expeditious delivery rollout, columnist Max Fawcett writes.
Experts say delaying the second dose of some COVID-19 vaccines could lead to the emergence of new variants of the virus — but there's no sign it has happened yet.
Prime Minister Justin Trudeau announced a tentative deal Tuesday with U.S. vaccine-maker Novavax to produce its product in Canada if the COVID-19 vaccine gets approved for use here.
The Trudeau government is being urged to follow the tough talk of Europe's health minister, who on Wednesday, January 27, 2021, accused a vaccine company of not living up to its moral and legal obligations because of delivery delays.
